Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

DELAYED PROGRESSION TO AIDS BY A MISSENSE ALLELE OF THE CCR2 GENE

  • Read more about DELAYED PROGRESSION TO AIDS BY A MISSENSE ALLELE OF THE CCR2 GENE
US Patent 6,600,030
Filed on 1998-08-10

Method of In Vitro T-Cell Differentiation Of CD34 Progenitor Cells

  • Read more about Method of In Vitro T-Cell Differentiation Of CD34 Progenitor Cells
Patent Cooperation Treaty
PCT/US2000/029655
Filed on 2000-10-27

METHOD FOR EARLY DETECTION OF LUNG CANCER

  • Read more about METHOD FOR EARLY DETECTION OF LUNG CANCER
US Patent 5,455,159
Filed on 1993-11-16

REAGENT AND METHOD FOR TARGETING RETROVIRUS

  • Read more about REAGENT AND METHOD FOR TARGETING RETROVIRUS
Patent Cooperation Treaty
PCT/US1997/006273
Filed on 1997-04-07

SPECTRAL CLONING-AN INNOVATIVE TECHNICAL AND CONCEPTUAL APPROACH TO THE CLONING AND CHARACTERIZATION OF EVERY CHROMOSOMAL ABBERRATION ...

  • Read more about SPECTRAL CLONING-AN INNOVATIVE TECHNICAL AND CONCEPTUAL APPROACH TO THE CLONING AND CHARACTERIZATION OF EVERY CHROMOSOMAL ABBERRATION ...
Patent Cooperation Treaty
PCT/US1998/013557
Filed on 1998-06-29

RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN

  • Read more about RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN
Patent Cooperation Treaty
PCT/US1998/003693
Filed on 1998-02-24

Methods of Diagnosing Potential for Metastasis or Developing Hepatocellular Carcinoma and of Identifying Therapeutic Targets

  • Read more about Methods of Diagnosing Potential for Metastasis or Developing Hepatocellular Carcinoma and of Identifying Therapeutic Targets
Patent Cooperation Treaty
PCT/US2003/010783
Filed on 2003-04-04

INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS

  • Read more about INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS
US Application 09/103,519
Filed on 1998-06-23

ENHANCED SUPPRESSION OF HIV-1 BY THE COMBINATION OF CYTIDINE NUCLEOSIDE ANALOGUES AND CTP SYNTHASE INHIBITORS.

  • Read more about ENHANCED SUPPRESSION OF HIV-1 BY THE COMBINATION OF CYTIDINE NUCLEOSIDE ANALOGUES AND CTP SYNTHASE INHIBITORS.
Patent Cooperation Treaty
PCT/US1998/000784
Filed on 1998-01-20

ANTITUMOR MACROCYCLIC LACTONES, COMPOSITIONS AND METHODS OF USE

  • Read more about ANTITUMOR MACROCYCLIC LACTONES, COMPOSITIONS AND METHODS OF USE
Patent Cooperation Treaty
PCT/US1998/015011
Filed on 1998-07-23

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1533
  • Page 1534
  • Page 1535
  • Page 1536
  • Page 1537
  • Page 1538
  • Page 1539
  • Page 1540
  • Page 1541
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health